Avalo Therapeutics, Inc. · NASDAQ:AVTX

Millennium Management LLC's stake in Avalo Therapeutics, Inc. fell to 4.90% (Schedule 13G)

Event Feb 3, 2026 · Filed Feb 10, 2026

Millennium Management LLC's stake in Avalo Therapeutics, Inc. fell to 4.90%, 906,762 shares, as a passive investor on Feb 3, 2026. Filed Feb 10, 2026 (Schedule 13G).

Stake
4.90%
Shares
906,762
Intent
Passive
What changed
Fell below 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Millennium Management LLC4.90%906,762
Millennium Group Management LLC4.90%906,762
Israel A. Englander4.90%906,762

Source

View original at SEC

Related